Home › Funds › Renaissance Technologies › DMAC
Renaissance Technologies position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
Latest position (Q1 2026)52.52K sh
Reported value held$355.58K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 33.62K | $53 | New |
| Q1 2023 | 64.51K | $99 | Add |
| Q1 2026 | 52.52K | $355.58K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DMAC
- BlackRock Inc 2.25M sh · $15.86M · Q2 2026
- Geode Capital Management 894.12K sh · $6.30M · Q2 2026
- Millennium Management 845.31K sh · $5.95M · Q2 2026
- Vanguard Group 723.12K sh · $5.76M · Q4 2025
- Northern Trust Corp 327.52K sh · $2.31M · Q2 2026
- Goldman Sachs Group 168.07K sh · $1.18M · Q2 2026
- Citadel Advisors 145.87K sh · $1.03M · Q2 2026
- BNY Mellon 117.82K sh · $829.45K · Q2 2026
- Charles Schwab Investment Management 96.69K sh · $680.71K · Q2 2026
- Bank of America Corp 57.71K sh · $406.29K · Q2 2026
- Morgan Stanley 46.87K sh · $329.99K · Q2 2026
- Wells Fargo & Co 36.93K sh · $259.97K · Q2 2026